about
Systemic treatments for metastatic cutaneous melanomaSystemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.BH3-based fusion artificial peptide induces apoptosis and targets human colon cancer.Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.Structural simplification of bioactive natural products with multicomponent synthesis. 4. 4H-pyrano-[2,3-b]naphthoquinones with anticancer activityBrain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating centerChemistry and biology of the caged Garcinia xanthones.Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activityLycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatmentAggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulationIn search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivativesInvolvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line.Melanoma-initiating cells: a compass needed.Identification of unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma by a large-scale synthetic lethal RNAi screening.DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo.Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents.Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2.Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines.
P2860
Q24194804-E92140DA-8760-4937-9B1A-6196637CE971Q30940472-B061DCC4-3E18-4CC1-80F0-5554AC36C27DQ33559683-C34BC218-52EC-4416-B37D-D0A15D970723Q33713980-34D0A419-F59B-4130-9150-30A26F80E543Q34279342-748A3E78-69AC-4602-A6A8-8742273DB11FQ34347010-89CBED82-257A-400F-9D38-BD43E4836D3DQ34552757-6A734853-0AAA-42AC-A556-53541097465EQ35129332-E1A99363-CE9E-47AC-85D7-5F221BEFEDAFQ35234721-6EEF767A-F68B-423B-91FE-5F0A2436D459Q35499214-8868AAAF-2F1F-420E-8E87-19F237CC75FAQ35588855-3428B054-4C0D-4209-A69F-3D534E869D55Q35893442-645FFCDD-51CC-485A-B4C6-53102193F06AQ36050683-7C039D20-236A-4FCF-9E3B-836197EB2C62Q36057981-04C8CFFF-6DB1-40BA-8559-E98315D43528Q37253732-26652CAC-F2E0-4ABC-B00E-5A910E5EE826Q37360062-ECBF3743-246F-4AF9-AFDC-53492E019B29Q37574031-CBE744FC-E39B-4DB1-A5F8-86168A81F1F1Q37636774-858CB03A-E816-4A40-9073-06A110520015Q39461572-3A87FC02-BADE-4E0F-A877-6338EB58CE01Q39516815-A47BA631-ABFE-4D4D-96F7-EE44510A5B7FQ41970695-8DF27E71-5598-460F-BEEB-D8BB0B3C6BE4
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Drug resistance in melanoma: new perspectives.
@ast
Drug resistance in melanoma: new perspectives.
@en
type
label
Drug resistance in melanoma: new perspectives.
@ast
Drug resistance in melanoma: new perspectives.
@en
prefLabel
Drug resistance in melanoma: new perspectives.
@ast
Drug resistance in melanoma: new perspectives.
@en
P1476
Drug resistance in melanoma: new perspectives
@en
P2093
Caterina A M La Porta
P304
P356
10.2174/092986707779941078
P577
2007-01-01T00:00:00Z